The Pennant Group, Inc.

NasdaqGS:PNTG Stock Report

Market Cap: US$1.4b

Pennant Group Valuation

Is PNTG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PNTG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: PNTG ($42.48) is trading below our estimate of future cash flow value ($82.25)

Significantly Below Future Cash Flow Value: PNTG is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PNTG?

Key metric: As PNTG is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for PNTG. This is calculated by dividing PNTG's market cap by their current earnings.
What is PNTG's PE Ratio?
PE Ratio45.9x
EarningsUS$32.32m
Market CapUS$1.40b

Price to Earnings Ratio vs Peers

How does PNTG's PE Ratio compare to its peers?

The above table shows the PE ratio for PNTG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average43.4x
ASTH Astrana Health
47.6x28.99%US$2.0b
ADUS Addus HomeCare
20.6x9.75%US$2.1b
PRVA Privia Health Group
92.5x30.29%US$2.6b
AMN AMN Healthcare Services
12.9x-120.91%US$1.3b
PNTG Pennant Group
45.9x28.23%US$1.4b

Price-To-Earnings vs Peers: PNTG is expensive based on its Price-To-Earnings Ratio (45.9x) compared to the peer average (43.4x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does PNTG's PE Ratio compare vs other companies in the US Healthcare Industry?

9 CompaniesPrice / EarningsEstimated GrowthMarket Cap
CYH Community Health Systems
1.6x-106.41%US$402.52m
IDXG.D Interpace Biosciences
1.4xn/aUS$36.01m
RHEP Regional Health Properties
0.9xn/aUS$3.96m
NIVF NewGenIvf Group
0.2xn/aUS$2.03m
PNTG 45.9xIndustry Avg. 24.7xNo. of Companies10PE020406080100+
9 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: PNTG is expensive based on its Price-To-Earnings Ratio (45.9x) compared to the US Healthcare industry average (24.7x).

Price to Earnings Ratio vs Fair Ratio

What is PNTG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PNTG PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio45.9x
Fair PE Ratio29.7x

Price-To-Earnings vs Fair Ratio: PNTG is expensive based on its Price-To-Earnings Ratio (45.9x) compared to the estimated Fair Price-To-Earnings Ratio (29.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PNTG forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$42.48
US$46.67
+9.86%
3.43%US$49.00US$44.00n/a6
Sep ’27US$37.74
US$46.67
+23.65%
3.43%US$49.00US$44.00n/a6
Aug ’27US$40.32
US$45.00
+11.61%
7.03%US$49.00US$40.00n/a6
Jul ’27US$37.36
US$40.83
+9.30%
2.20%US$42.00US$40.00n/a6
Jun ’27US$32.00
US$40.83
+27.60%
2.20%US$42.00US$40.00n/a6
May ’27US$31.30
US$38.17
+21.94%
4.64%US$41.00US$36.00n/a6
Apr ’27US$30.35
US$37.83
+24.66%
5.99%US$41.00US$34.00n/a6
Mar ’27US$33.71
US$37.50
+11.24%
5.05%US$40.00US$34.00n/a6
Feb ’27US$27.62
US$37.50
+35.77%
5.05%US$40.00US$34.00n/a6
Jan ’27US$28.15
US$36.33
+29.07%
8.36%US$40.00US$31.00n/a6
Dec ’26US$28.40
US$33.67
+18.54%
12.33%US$39.00US$28.00n/a6
Nov ’26US$24.73
US$33.00
+33.44%
13.32%US$40.00US$28.00n/a6
Oct ’26US$25.40
US$33.60
+32.28%
13.65%US$40.00US$28.00n/a5
Sep ’26US$24.01
US$33.60
+39.94%
13.65%US$40.00US$28.00US$37.745
Aug ’26US$22.07
US$33.60
+52.24%
6.41%US$37.00US$31.00US$40.325
Jul ’26US$27.02
US$33.60
+24.35%
6.41%US$37.00US$31.00US$37.365
Jun ’26US$28.71
US$33.00
+14.94%
7.73%US$37.00US$30.00US$32.004
May ’26US$25.42
US$31.25
+22.93%
10.94%US$37.00US$28.00US$31.304
Apr ’26US$25.41
US$32.60
+28.30%
12.51%US$38.00US$28.00US$30.355
Mar ’26US$22.77
US$36.00
+58.10%
8.43%US$40.00US$32.00US$33.715
Feb ’26US$26.47
US$36.00
+36.00%
8.43%US$40.00US$32.00US$27.625
Jan ’26US$26.52
US$37.20
+40.27%
6.22%US$40.00US$33.00US$28.155
Dec ’25US$31.18
US$38.25
+22.67%
2.85%US$40.00US$37.00US$28.404
Nov ’25US$32.49
US$37.50
+15.42%
5.81%US$40.00US$34.00US$24.734
Oct ’25US$32.92
US$33.50
+1.76%
14.85%US$40.00US$26.00US$25.404
Sep ’25US$34.26
US$31.50
-8.06%
10.41%US$34.00US$26.00US$24.014
US$46.67
Fair Value
9.0% undervalued intrinsic discount
6
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/16 21:43
End of Day Share Price 2026/09/16 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

The Pennant Group, Inc. is covered by 8 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian TanquilutJefferies LLC
Michael WiederhornOppenheimer & Co. Inc.
Benjamin HendrixRBC Capital Markets